24,389 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by PVG Asset Management Corp

PVG Asset Management Corp acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 24,389 shares of the pharmacy operator's stock, valued at approximately $228,000.

Other institutional investors have also modified their holdings of the company. Metis Global Partners LLC grew its stake in Walgreens Boots Alliance by 4.9% during the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock worth $222,000 after buying an additional 1,118 shares during the period. Harbour Investments Inc. grew its stake in Walgreens Boots Alliance by 4.3% during the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock worth $265,000 after buying an additional 1,165 shares during the period. Unison Advisors LLC grew its stake in Walgreens Boots Alliance by 2.8% during the fourth quarter. Unison Advisors LLC now owns 43,226 shares of the pharmacy operator's stock worth $403,000 after buying an additional 1,168 shares during the period. Avantax Advisory Services Inc. grew its stake in Walgreens Boots Alliance by 2.4% during the fourth quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator's stock worth $466,000 after buying an additional 1,186 shares during the period. Finally, HBK Sorce Advisory LLC grew its stake in Walgreens Boots Alliance by 10.4% during the fourth quarter. HBK Sorce Advisory LLC now owns 12,591 shares of the pharmacy operator's stock worth $117,000 after buying an additional 1,188 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Down 0.2%

WBA traded down $0.02 during trading on Wednesday, hitting $11.19. The company had a trading volume of 8,657,737 shares, compared to its average volume of 20,868,608. The company has a market cap of $9.68 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.77. The business has a 50-day moving average of $11.03 and a 200-day moving average of $10.45. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $16.34.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm's revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.20 earnings per share. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the company's stock in a transaction on Sunday, April 27th. The shares were bought at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the acquisition, the chairman now owns 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on WBA. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Wall Street Zen began coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating for the company. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Finally, Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.